CHEST webinar: Covid-19 and VTE: Key takeaways

This newsletter will shed light upon following key aspects :

High cumulative incidence of thrombotic complications in critically-ill patients with Covid-19 pneumonia
Anticoagulant therapy mainly with LMWH and its association with decreased mortality in severe Covid-19 patients with coagulopathy
Recommendation of anticoagulant thromboprophylaxis with LMWH or UFH in critically ill patients with Covid-19 over fondaparinux or DOAC